Nova Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$343K Buy
286
+32
+13% +$32.7K 0.19% 111
2026
Q1
$233K Sell
254
-27
-10% -$27.4K 0.15% 124
2025
Q4
$302K Sell
281
-10
-3% -$9.56K 0.21% 105
2025
Q3
$222K Sell
291
-76
-21% -$56.6K 0.16% 121
2025
Q2
$286K Sell
367
-129
-26% -$100K 0.21% 105
2025
Q1
$410K Sell
496
-124
-20% -$103K 0.35% 74
2024
Q4
$479K Buy
+620
New +$513K 0.41% 57

Other funds holding LLY

Nova Wealth Management's LLY Position: Q2 2026 in Review

Nova Wealth Management increased its Eli Lilly (LLY) stake by 13% in Q2 2026, buying an estimated $32.7K and bringing the position to 286 shares worth $343K. The position accounts for 0.19% of the portfolio, ranked #111.

Nova Wealth Management first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. The position peaked at $479K in Q4 2024. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Nova Wealth Management held 286 shares of Eli Lilly worth $343K as of Q2 2026.
  • Nova Wealth Management bought 32 Eli Lilly shares in Q2 2026, an estimated $32.7K.
  • Eli Lilly made up 0.19% of Nova Wealth Management's portfolio in Q2 2026, its #111 holding.
  • Nova Wealth Management first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • Nova Wealth Management's Eli Lilly position peaked at $479K in Q4 2024.
  • 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Nova Wealth Management's 13F filing for Q2 2026, filed 13 Jul 2026.